BioCryst Pharma (BCRX.US) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Dec3

BioCryst Pharmaceuticals Plans to Merge with Astria Therapeutics

12:00

Nov12

BioCryst Pharmaceuticals to Acquire Astria Therapeutics for $8.55 per Share and 0.59 Shares

13:03

Nov8

HC Wainwright Raises BioCryst Pharmaceuticals' EPS Forecast for FY2025

14:20

Nov6

BioCryst Pharmaceuticals Releases ORLADEYO® Clinical Trial Data

13:00

Nov3

Belanger Maintains BioCryst's Stock Rating

21:56

BioCryst Pharma released FY2025 Q3 earnings on November 3 Pre-Market EST, actual revenue USD 159.4 M (forecast USD 162.97 M), actual EPS USD 0.06 (forecast USD 0.0528)

14:30

Schedules & Filings

Schedules

Filings

Nov3

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 159.4 M, Net Income 12.9 M, EPS 0.06

Aug4

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 163.35 M, Net Income 5.085 M, EPS 0.02

May5

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 145.53 M, Net Income 32 K, EPS 0.0001

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change